Vaxxinity Inc - Class A

NAS:VAXX (USA)   Class A
$ 0.12 -0.0081 (-6.6%) 09:08 PM EST
At Loss
P/B:
1.04
Market Cap:
$ 14.78M
Enterprise V:
$ 236.00K
Volume:
2.36M
Avg Vol (2M):
986.19K
Volume:
2.36M
At Loss
Avg Vol (2M):
986.19K

Business Description

Vaxxinity Inc
NAICS : 541714 SIC : 2834
ISIN : US92244V1044

Share Class Description:

VAXX: Class A
Description
Vaxxinity Inc is a biotechnology company committed to democratizing healthcare across the globe. The company is pioneering a new class of synthetic, peptide-based active immunotherapy medicines aimed at disrupting the existing treatment paradigm for chronic disease, increasingly dominated by monoclonal antibodies, which suffer from prohibitive costs and cumbersome administration. The company's proprietary technology platform has enabled the innovation of novel pipeline candidates designed to bring the efficiency of vaccines to the treatment of chronic diseases, including Alzheimer's, Parkinson's, migraine, and hypercholesterolemia.

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -11.9
3-Year EPS without NRI Growth Rate -18.9
3-Year FCF Growth Rate -17.4

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 19.99
9-Day RSI 18.37
14-Day RSI 20.47
6-1 Month Momentum % -39.32
12-1 Month Momentum % -68.16

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.89
Quick Ratio 1.89
Cash Ratio 1.73

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.5
Shareholder Yield % -16.34
Name Current Vs Industry Vs History
ROE % -157.77
ROA % -77.97
ROIC % -393.23
ROC (Joel Greenblatt) % -480.86
ROCE % -114.9

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 1.04
Price-to-Tangible-Book 1.06
Price-to-Net-Current-Asset-Value 5.83
FCF Yield % -399.51